Cargando…

Treatment Pattern of Antithrombotic Therapy over Time after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation in Real-World Practice in Korea

We examined antithrombotic treatment patterns with clinical characteristics and therapy changes over time in patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI). Using the Health Insurance Review and Assessment service claims database (01JAN2007-30NOV2016) in Korea,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Seongwook, Han, Sola, Jang, Sung-Won, Lee, Myung-Yong, On, Young-Keun, Bang, Oh Young, Lee, Ji-Min, Park, Yoo-Jung, Shin, Ji-Soo, Kang, Seongsik, Suh, Hae Sun, Kim, Young-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472294/ https://www.ncbi.nlm.nih.gov/pubmed/34574959 http://dx.doi.org/10.3390/healthcare9091185

Ejemplares similares

Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)

Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
por: Han, Seongwook, et al.
Publicado: (2021)

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
por: Han, Sola, et al.
Publicado: (2021)

The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis
por: Bang, Oh Young, et al.
Publicado: (2020)

Antithrombotic treatments in patients with acute ischemic stroke and non-valvular atrial fibrillation before introduction of non-vitamin K antagonist oral anticoagulants into practice in Korea
por: Bae, Hee-Joon, et al.
Publicado: (2018)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
por: Kwak, Soongu, et al.
Publicado: (2019)

Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation After Coronary Stent Implantation
por: Jang, Sung-Won, et al.
Publicado: (2011)

Gaps between Real-world Practice and Guidelines in Managing Patients with Atrial Fibrillation in Korea
por: Park, Hyoung-Seob, et al.
Publicado: (2017)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Atrial fibrillation in patients with first-ever stroke: Incidence trends and antithrombotic therapy before the event
por: Jung, Yo Han, et al.
Publicado: (2018)

Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
por: Huisman, M. V.
Publicado: (2021)

Adherence to Guidelines for Antithrombotic Therapy in Patients with Atrial Fibrillation According to CHADS2 Score before and after Stroke: A Multicenter Observational Study from Korea
por: Kim, Wook-Joo, et al.
Publicado: (2016)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study
por: Park, Jiesuck, et al.
Publicado: (2019)

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021)

Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Atrial fibrillation and percutaneous coronary intervention: Are newer antithrombotic agents better for older patients?
por: Leggio, Massimo, et al.
Publicado: (2018)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
por: Fan, Yongqiang, et al.
Publicado: (2022)

Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention
por: Poirier, Caylie M., et al.
Publicado: (2023)

Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis
por: Li, Jing-Xiu, et al.
Publicado: (2018)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
por: De Luca, Leonardo, et al.
Publicado: (2022)

Impact of Integrating Machine Learning in Comparative Effectiveness Research of Oral Anticoagulants in Patients with Atrial Fibrillation
por: Han, Sola, et al.
Publicado: (2022)

Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
por: Jung, Keun-Hwa, et al.
Publicado: (2015)

Percutaneous Left Atrial Appendage Occlusion Yields Favorable Neurological Outcomes in Patients with Non-Valvular Atrial Fibrillation
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
por: Shim, Jaemin, et al.
Publicado: (2021)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Koziński, Marek, et al.
Publicado: (2020)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Evolution of and Evidence-Practice Gaps in Antithrombotic Management of Atrial Fibrillation Patients After Percutaneous Coronary Intervention
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society
por: Jung, Byung Chun, et al.
Publicado: (2015)

The use of antithrombotics in patients presenting with stroke and atrial fibrillation
por: Burgess, Carl, et al.
Publicado: (2007)

Update on Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation
por: Abcede, Hermelinda G., et al.
Publicado: (2010)

The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019)

Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community
por: Joosten, L. P. T., et al.
Publicado: (2022)

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
por: Bang, Oh Young, et al.
Publicado: (2016)

Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
por: Park, Jiesuck, et al.
Publicado: (2021)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

Evolution of Antithrombotic Management of Atrial Fibrillation After Percutaneous Coronary Intervention Over 10 Years and Guidelines Uptake
por: Beaulieu, Marie-Claude, et al.
Publicado: (2021)

Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
por: Kim, Sung Soo, et al.
Publicado: (2021)

The Impact of Prior Antithrombotic Use on Blood Viscosity in Cardioembolic Stroke with Non-Valvular Atrial Fibrillation
por: Jung, Yo-Han, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lu2arq921i4qmlig4tfl8u68a3